Item Type | Name |
Academic Article
|
Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.
|
Academic Article
|
Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.
|
Academic Article
|
Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
|
Academic Article
|
Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.
|
Academic Article
|
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.
|
Academic Article
|
Design of HIV-1 protease inhibitors active on multidrug-resistant virus.
|
Academic Article
|
Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
|
Academic Article
|
Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease.
|
Academic Article
|
How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.
|
Academic Article
|
Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
|
Academic Article
|
Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis.
|
Academic Article
|
Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
|
Academic Article
|
Viral protease inhibitors.
|
Academic Article
|
Additivity in the analysis and design of HIV protease inhibitors.
|
Academic Article
|
Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis.
|
Academic Article
|
Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease.
|
Academic Article
|
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
|
Academic Article
|
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones.
|
Academic Article
|
Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.
|
Academic Article
|
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.
|
Academic Article
|
Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
|
Academic Article
|
Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.
|
Academic Article
|
Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.
|
Academic Article
|
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.
|
Academic Article
|
Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.
|
Academic Article
|
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.
|
Academic Article
|
Structure-based prediction of potential binding and nonbinding peptides to HIV-1 protease.
|
Academic Article
|
Covariation of amino acid positions in HIV-1 protease.
|
Academic Article
|
Combating susceptibility to drug resistance: lessons from HIV-1 protease.
|
Academic Article
|
Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.
|
Academic Article
|
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance.
|
Academic Article
|
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
|
Academic Article
|
Substrate specificity in HIV-1 protease by a biased sequence search method.
|
Academic Article
|
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
|
Academic Article
|
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.
|
Academic Article
|
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
|
Academic Article
|
Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease.
|
Academic Article
|
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
|
Academic Article
|
Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.
|
Academic Article
|
HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants.
|
Academic Article
|
Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.
|
Academic Article
|
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
|
Academic Article
|
New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors.
|
Academic Article
|
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
|
Academic Article
|
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
|
Academic Article
|
Rationale for more diverse inhibitors in competition with substrates in HIV-1 protease.
|
Academic Article
|
TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors.
|
Academic Article
|
Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV binding.
|
Academic Article
|
Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.
|
Academic Article
|
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.
|
Academic Article
|
Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50.
|
Academic Article
|
Interview with Celia Schiffer.
|
Concept
|
HIV Protease
|
Concept
|
HIV Protease Inhibitors
|
Academic Article
|
A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid.
|
Academic Article
|
Testing the substrate-envelope hypothesis with designed pairs of compounds.
|
Academic Article
|
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
|
Academic Article
|
HIV-1 protease-substrate coevolution in nelfinavir resistance.
|
Academic Article
|
Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.
|
Academic Article
|
Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.
|
Academic Article
|
Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.
|
Academic Article
|
A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.
|
Academic Article
|
Modulation of HIV protease flexibility by the T80N mutation.
|
Academic Article
|
Improving Viral Protease Inhibitors to Counter Drug Resistance.
|
Academic Article
|
Interdependence of Inhibitor Recognition in HIV-1 Protease.
|
Academic Article
|
Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.
|
Academic Article
|
Hydration Structure and Dynamics of Inhibitor-Bound HIV-1 Protease.
|
Academic Article
|
Probing Structural Changes among Analogous Inhibitor-Bound Forms of HIV-1 Protease and a Drug-Resistant Mutant in Solution by Nuclear Magnetic Resonance.
|
Academic Article
|
HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
|
Academic Article
|
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.
|
Academic Article
|
Constrained Mutational Sampling of Amino Acids in HIV-1 Protease Evolution.
|
Academic Article
|
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.
|
Academic Article
|
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.
|
Academic Article
|
Target-Specific Prediction of Ligand Affinity with Structure-Based Interaction Fingerprints.
|
Academic Article
|
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.
|
Academic Article
|
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
|
Academic Article
|
Characterizing Protein-Ligand Binding Using Atomistic Simulation and Machine Learning: Application to Drug Resistance in HIV-1 Protease.
|
Academic Article
|
Optimizing the refinement of merohedrally twinned P61 HIV-1 protease-inhibitor cocrystal structures.
|
Academic Article
|
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
|
Academic Article
|
Deciphering Complex Mechanisms of Resistance and Loss of Potency through Coupled Molecular Dynamics and Machine Learning.
|